Should Non-ST-Elevation Myocardial Infarction be Treated like ST-Elevation Myocardial Infarction With Shorter...

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Coronary Syndromes

Background:

• Non-ST-elevation myocardial infarction (NSTEMI) is a common acute coronary syndrome.
• The optimal timing for percutaneous coronary intervention (PCI) in NSTEMI patients is not well-established.
• This study investigates the impact of PCI timing on major adverse cardiac events (MACE).

Purpose of the Study:

• To evaluate the effect of percutaneous coronary intervention (PCI) timing on 1-year major adverse cardiac events (MACE) in patients with non-ST-elevation myocardial infarction (NSTEMI).

Main Methods:

• Retrospective analysis of 1550 NSTEMI patients undergoing PCI.
• Patients categorized into three groups based on door-to-balloon time (D2BT): <90 minutes, 90 minutes to 24 hours, and >24 hours.
• Primary outcome: MACE (MI, death, TVR) or TVR at 1 year.

Main Results:

• Baseline characteristics differed significantly across groups, with later PCI patients being older and having more comorbidities.
• Patients undergoing PCI between 90 minutes and 24 hours had significantly lower 1-year MACE/TVR.
• Higher MACE/TVR in the <90 minutes and >24 hours groups was driven by increased mortality.

Conclusions:

• Treatment selection bias complicates the interpretation of rapid revascularization's effect on NSTEMI outcomes.
• Patients undergoing PCI between 90 minutes and 24 hours demonstrated better 1-year outcomes.
• Randomized clinical trials are necessary to definitively assess the outcomes of rapid revascularization in NSTEMI.